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1. Introduction
  Jaundice, also called hyperbilirubinemia, refers to the stained 
yellow of sclera and skin caused by the increased production or 
acatharsia of bilirubin[1]. In neonatal peroid, because of the over-
production of bilirubin, liver could not intake and transform 
bilirubin efficiently accompanying with the particular enterohepatic 
circulation of bilirubin, which results in the common incidence 
of hyperbilirubinemia. Children with severe jaundice showed the 
reduced CD4+ cells, CD8+ cells, CD4+/CD8+ and CD4+/Fas with 
decreased IgG, IgA and IgM, which implied that hyperbilirubinemia 
could inhibit the children’s immune function[2]. Bilirubin has 
potential toxicity, free bilirubin can gather and damage the brain, 
heart, kidney, stomach and intestine, lung and immune tissues 
and cells through the biomembrane[3]. When the concentration of 
free bilirubin increased, it could form stable bilirubin free radical, 
leading to the lipid peroxidation injury[4]. 
  Neonate jaundice is related to the increasing blood unconjugated 
bilirubin (UCB) that is from the disintegrated red blood cells. 
Bilirubin can damage nervous tissue and evoke neurological 
dysfunction[5]. Moreover, increasing bilirubin can also lead to 
multiple dysimmunity, including humoral immune abnormalities, 
T cell subsets imbalance, and abnormal cytokine production and 
so on. For example, bilirubin could inhibit CD4+ cellular immune 
response through various ways and high-concentraion bilirubin 
could induce CD4+ cell apoptosis[6]. However, bilirubin is not 
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with NS group, MyD88 expression level in low-dose group elevated while p-TAK1 level in 
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always to impair the tissues in vivo, instead, it could exert physical 
protection effect through its antioxidat properties[7].
  Currently, there are no more profound and comprehensive studies 
about the relationship of immune function and bilirubin. In the 
study, we simulated the inner environment of human body through 
establishing the hyperbilirubinemia model in neonatal SD rats, in 
order to observe how the bilirubin influencing immune system under 
multiple regulatory mechanisms and explore the causes of immune 
dysfunction in neonates with jaundice. 
2. Materials and methods
2.1. Experimental animals and grouping
  A total of 60 SD neonatal rats were selected without differentiating 
male or female, aging 7-8 days and weighing 12.0-15.0 g. They were 
divided into 5 groups (n=12) randomly: normal saline (NS) group, 
LPS control group, bilirubin bontrol group, low-dose group and 
high-dose group; each group was divided into two sub-groups: 5h 
sub-group and 24h sub-group (n=6).
2.2. Establishment of rats model with jaundice
  After anesthesia, newborn SD rats were fixed, their necks were 
disinfected, and jugular vein exposed. 0.1 mL NS was given to 
the rats in NS group and LPS control group; bilirubin control 
group, low-dose group and high-dose group were given bilirubin 
through intravenous injecting at 15 mg/kg, 15 mg/kg and 50 mg/kg, 
respectively. 1 h later, NS group and bilirubin control group received 
the intraperitoneal injection of 0.05 mL NS and the other groups 
received the injection of LPS (1 mg/kg). After all the processes, all 
the newborn rats were sent back to their mothers.
  After 10 min, 30 min, 60 min, 120 min, 300 min and 480 min of 
administration, the experimental rats were anesthetized for collecting 
blood samples. After the centrifugation at 3 000 rpm for 5 min, the 
plasma was obtained and plasma bilirubin content was determind by 
automatic biochemical analyzer.
2.3. Determination of myeloid differentiation factor 88 
(MyD88) expression and transforming growth factor-毬
-activating kinase 1 (TAK1) phosphorylation and spleen cell 
apoptosis
  After 5 h and 24 h of administration, animals were sacrificed to 
take out the spleen. The spleens were firstly fixed by 4% paraform 
at 4 曟 for 6-12 h. Then spleen tissue paraffin sections were 
made for detecting MyD88 and p-TAK1 protein expression by 
immunohistochemistry. Image-Pro Plus6.0 software was used to 
determine the integrated optical density (IOD), 3 horizons were 
randomly selected and the average IOD represented the target 
protein expression level.
  Apoptosis rate of spleen cells after 24 hours of administration was 
detected by TUNEL method. 
Apoptotic index (AI)=(apoptotic number/400)×100%.
2.4. Determination of serum cytokines levels and T cell 
subsets distribution
  After 24 hours of administration, the animal blood sample was 
collected and centriguged ar 1 500 rpm for 5 min. Then, IL-6 and 
IL-8 levels in serum were detected by ELISA; the percentage of 
CD4+ and CD8+ cells and the ratio of CD4+/CD8+ were analyzed by 
flow cytometry.
2.5. Data statistics analysis
  SPSS16.0 software was used to process the data. Date in normal 
distribution was symbolized by mean±SD otherwise data was 
symbolized by the median. When homogenetity of variance was 
satisfied One-Way ANOVA was used to analyze otherwise the 
Kruskal-Wallis Test would be used. When P<0.05, the difference 
was statistically significant. 
3. Results
3.1. Bilirubin level at different time points after administraion
  Figure 1 showed that after 1 hour of administration, the 95% 
confidence intervals of bilirubin concentration in low-dose group 
and high-dose group were 104.8-120.2 μmol/L and 195.8-238.1 
μmol/L, respectively, accordant with the expected range of bilirubin 
level [the bilirubin level of newborn children with jaundice was 
about 102.6 μmol/L (6 mg/L)]. So it was thought that the rats model 
of hyperbilirubinemia was established successful. 
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Figure 1. Bilirubin concentration-time curves of low-dose and high-dose 
group.
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3.2. Expressions levels of MyD88 and p-TAK1 and spleen 
cells apoptosis    
  Results in Figure 2 showed that single injection of bilirubin or 
LPS both could induce the increasing spleen cells apoptosis rate 
(P<0.05), high-dose bilirubin (50 mg/kg) could induce the apoptosis 
in coordination with LPS (P<0.05), while low-dose bilirubin (15 mg/
kg) did not display the synergistic effect. Compred with NS group, 
MyD88 expression level of low-dose group raised obviously and 
p-TAK1 level of high-dose group reduced (P<0.05) after 5 hour of 
administration (Figure 3). 
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Figure 2. Spleen cells apoptosis after 24 hours of administration.
a: NS group; b: LPS control group; c: bilirubin control group; d: low-dose 
group; e: high-dose group.
Note: *compared with NS group, P<0.05; #compred with LPS control group, 
P<0.05. The next figure is same.
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Figure 3. Expression levels of MyD88 and p-TAK1 protein after 5 or 24 
hours of administration.
3.3. Serum cytokines levels and T cell subsets distribution
  Cytokines levels in LPS control group and high-dose group were 
both higher than those in NS group, those in high-dose group were 
also simultaneously higher than LPS control group (P<0.05) while 
cytokines levels in low-dose group were lower than LPS control 
group (P<0.05) (Figure 4). These results indicated that high-
dose bilirubin (50 mg/kg) could induce inflammatory reaction in 
coordination with LPS while low-dose bilirubin (15 mg/kg) could 
inhibition the inflammatory reaction induced by LPS. 
  Moreover, in high-dose group, percentage of CD4+ T cells was 
lower than NS group and percentage of CD8+ T cells was higher 
than NS group and LPS control group (P<0.05), which implied that 
severe immune dysfunction existed in rats of high-dose group.
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Figure 4. Content of serum IL-6, IL-8 and plasma CD4+, CD8+ T cells.
4. Discussion
  In the study, we induced the slight inflammatory reaction by LPS 
injection, meanwhile, we injected different doses of bilirubin to 
observe the synergistic effect of bilirubin and LPS on inflammation 
and immune system. Our results showed that LPS could induce the 
up-regulation of MyD88 and p-TAK1 protein expression while high-
dose bilirubin abolished the up-regulation. High-dose bilirubin could 
aggravate the inflammatory reaction in coordination with LPS while 
low-dose bilirubin alleviated the inflammation. Besides, rats of high-
dose group showed severe immune dysfunction.
  Many studies showed that high-concentration bilirubin could 
lead to the injury of multi-systems and multi-organs especially in 
neonates[8,9]. Berns et al separated the cortical neurons of Wistar rat 
embryos for primary culture, and then high-concentration bilirubin 
was added to imitate hyperbilirubinemia and their results showed that 
high-concentration bilirubin can increase the neurons apoptosis[10]. 
In the study of substances causing cerebral injury after intracerebral 
hemorrhage, Lakovic et al[11] found that 0.5 mmol/L bilirubin 
treatment damaged the function and the structure of myelinated 
axons and bilirubin oxidation products may be responsible for the 
toxicity of bilirubin.
  MyD88 is the crucial adapter protein of Toll-like receptors 
(TLRs) signal pathways. It transfers the LPS inflammatory signals 
recognized by Toll-like receptor 4 (TLR4) into cells[12]. In the 
body, LPS firstly activates TLR4 through preprecessing way, then 
it activates the downstream fator including MAPK, p38 and ERK 
through MyD88, which leads to the activation and translocating 
into nucleus of NF-毷B and consequently induces the inflammation 
cascade. TAK1 is the member of MAP3K family, its elevated 
activity could activate NF-毷B signal pathway and trigger cascade, 
thus TAK1 regulates multiple effect genes expression. TAK1 also 
participates in regulating NF-毷B signal pathway mediated by 
B cell receptor, and it is necessary for B cells to secrete various 
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immunoglobulins[13]. In the study, high-dose bilirubin inhibited 
the MyD88 and p-TAK1 expression, which indicated that high-
concentraion plasma biliburin could restrain signal transduction 
mediated by NF-毷B.On the other hand, NF-毷B is closely related 
to innate immune function[14]. When Bhakar et al researched 
NF-毷B transcriptional activity, they found the mice immune 
organs atrophied and significant neurons death after blocking the 
activation of NF-毷B[15]. Bureau et al blocked NF-毷B in silent 
lymphocytes, granulocytes and monocytes through special medicine, 
which resulted in the increasing apoptosis of lymphocytes and 
granulocytes[16]. Moreover, NF-毷B also takes part in the expression 
regulation of important immune receptors and immunoglobulins 
and the antigen presentation[17-19]. Herbst et al identified inhibition 
of a newly discovered macrophage TLR9-BTK-calcineurin-NFAT 
signalling pathway as a key immune defect that leads to organ 
transplant-related invasive aspergillosis[20]. In our study, because 
high-dose bilirubin obviously restrained the up-regulation of MyD88 
and p-TAK1 expression, the activation of NF-毷B and NF-毷B 
signal pathway were inhibited to a great extent, and eventually the 
initiation of immune response was restrained[21,22]; meanwhile, 
high-concentraion bilirubin induced high level of inflammatory 
factors causing interactive activation with immune cells and 
inflammation cascade, and inflammation cascade in coordination 
with immunosuppression induced by high-dose bilirubin produced 
immune dysfunction ultimately.
  In conclusion, in neonatal rats with hyperbilirubinemia, high-
concentration bilirubin aggravated inflammatory reaction induced 
by LPS and produced inflammation cascade; meanwhile, it in 
coordination with LPS inhibited NF-毷B signal pathways activation 
and caused immunosuppression which resulted in the immune 
dysfunction in synergy with inflammation cascade eventually.
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